| Jeremy R Luedtke, MD | |
|
400 Legacy Plz W, La Porte, IN 46350-5296 | |
| (219) 379-3166 | |
| (219) 324-9730 |
| Full Name | Jeremy R Luedtke |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | 400 Legacy Plz W, La Porte, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891900783 | NPI | - | NPPES |
| 07028 | Other | WI | MEDICARE # |
| 300008363 | Medicaid | IN | |
| IN2920085 | Other | IN | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 4301087609 (Michigan) | Secondary |
| 208600000X | Surgery | 57033-20 (Wisconsin) | Secondary |
| 208600000X | Surgery | 01079264A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Medical Center - Shawano | Shawano, WI | Hospital |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Surgical Associates Of Neenah, S.c. | 4486625258 | 28 |
News Archive
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
A team headed by Vincent Pasque at his Lab at KU Leuven alongside researchers from the Jean-Christophe Marine lab and the Edith Heard lab have made a significant step towards developing a treatment for Rett syndrome and other X chromosome linked disorders.
For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
A recent perspective article published in the prestigious journal Science highlights how the use of network-driven strategies for adequately informing rapidly emergent epidemic responses is not only evidence-based but also an equitable way forward for the current coronavirus disease (COVID-19) pandemic and future respiratory pandemics.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 2 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
A team headed by Vincent Pasque at his Lab at KU Leuven alongside researchers from the Jean-Christophe Marine lab and the Edith Heard lab have made a significant step towards developing a treatment for Rett syndrome and other X chromosome linked disorders.
For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
A recent perspective article published in the prestigious journal Science highlights how the use of network-driven strategies for adequately informing rapidly emergent epidemic responses is not only evidence-based but also an equitable way forward for the current coronavirus disease (COVID-19) pandemic and future respiratory pandemics.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 2 days ago
| Entity Name | Surgical Associates Of Neenah, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285792341 PECOS PAC ID: 4486625258 Enrollment ID: O20040804001098 |
News Archive
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
A team headed by Vincent Pasque at his Lab at KU Leuven alongside researchers from the Jean-Christophe Marine lab and the Edith Heard lab have made a significant step towards developing a treatment for Rett syndrome and other X chromosome linked disorders.
For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
A recent perspective article published in the prestigious journal Science highlights how the use of network-driven strategies for adequately informing rapidly emergent epidemic responses is not only evidence-based but also an equitable way forward for the current coronavirus disease (COVID-19) pandemic and future respiratory pandemics.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy R Luedtke, MD 400 Legacy Plz W, La Porte, IN 46350-5296 Ph: (219) 379-3166 | Jeremy R Luedtke, MD 400 Legacy Plz W, La Porte, IN 46350-5296 Ph: (219) 379-3166 |
News Archive
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
A team headed by Vincent Pasque at his Lab at KU Leuven alongside researchers from the Jean-Christophe Marine lab and the Edith Heard lab have made a significant step towards developing a treatment for Rett syndrome and other X chromosome linked disorders.
For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
A recent perspective article published in the prestigious journal Science highlights how the use of network-driven strategies for adequately informing rapidly emergent epidemic responses is not only evidence-based but also an equitable way forward for the current coronavirus disease (COVID-19) pandemic and future respiratory pandemics.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 2 days ago
Christopher Adam Conn, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Legacy Plz W, La Porte, IN 46350 Phone: 219-379-3166 Fax: 219-324-9730 | |
Brian G Moore, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 I St Fl 2, La Porte, IN 46350 Phone: 219-575-6060 Fax: 219-575-6004 | |
Dr. Dorene Kay Zerfas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 Lincolnway, Suite 304, La Porte, IN 46350 Phone: 219-362-8523 Fax: 219-324-9396 | |
Dr. Steven William Chmil, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 901 Lincolnway, Suite 304, La Porte, IN 46350 Phone: 219-362-8523 Fax: 219-324-9396 | |
Dr. David Samuel Mendelowitz, MD Surgery Medicare: Medicare Enrolled Practice Location: 1300 State Street, Suite 2c, La Porte, IN 46350 Phone: 219-325-0152 Fax: 219-325-8621 | |
James T Cornwell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 I St, La Porte, IN 46350 Phone: 219-324-1700 Fax: 219-324-1602 |